Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of ...
Orforgliprion caused an average 11% weight loss among overweight and obese people after a year and a half, researchers ...
Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback